Dexco revenue and financials
R$6.81Change from previous close: +10.37%Absolute change: +R$0.64
In the fiscal year ended December 2025, Dexco reported revenue of R$8.25B (+0.17% year over year). Net income was R$1.18M, a net margin of 0.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +0.17%
- 2025 vs 2024
- Net income growth
- −99.31%
- 2025 vs 2024
- Net margin
- 0.0%
- 2024: 2.1%
Financial data
Amounts in millions of BRL; per-share values in BRL; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 19,001 | 18,144 | 17,971 | 15,625 | — |
| Current assets | 6,048 | 5,066 | 5,900 | 5,174 | — |
| Cash and equivalents | 2,178 | 1,231 | 2,785 | 1,772 | — |
| Short-term investments | 351 | 522 | — | — | — |
| Inventory | 1,713 | 1,633 | 1,539 | 1,605 | — |
| Net property, plant and equipment | 5,154 | 5,316 | 4,996 | 4,512 | — |
| Goodwill | 407 | 382 | 382 | 432 | — |
| Other intangible assets | 426 | 452 | 481 | 446 | — |
| Long-term investments | 2,359 | 2,394 | 1,858 | 1,747 | — |
| Current liabilities | 2,701 | 3,642 | 3,609 | 3,265 | — |
| Accounts payable | 1,136 | 1,262 | 1,175 | 1,236 | — |
| Long-term debt | 7,067 | 5,216 | 5,873 | 4,838 | — |
| Total debt | 8,482 | 7,253 | 7,714 | 6,202 | — |
| Total liabilities | 11,793 | 10,949 | 11,449 | 9,663 | — |
| Total equity (incl. minority) | 7,208 | 7,195 | 6,522 | 5,962 | — |
| Minority interest | 361 | 218 | 118 | 89.2 | — |